BNTX financial statements
The full income statement, balance sheet, and cash-flow statement for BioNTech SE American Depositary Share (BNTX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 3.25B+9.1% | 2.98B-27.9% | 4.13B-77.3% | 18.2B-18.9% | 22.4B+3981.8% | |
| Cost of revenue | 726M+24.0% | 586M-9.7% | 649M-79.4% | 3.15B-8.5% | 3.44B+4993.4% | |
| Research & development | 2.38B-2.3% | 2.44B+26.5% | 1.93B+19.3% | 1.62B+44.0% | 1.12B+52.7% | |
| Operating income | -1.59B-11.8% | -1.42B-290.4% | 747M-94.4% | 13.3B-26.4% | 18.1B+19341.9% | |
| Interest expense | 79.0M+166.5% | 29.6M+14.7% | 25.8M+30.0% | 19.9M-94.5% | 361M+386.9% | |
| Pre-tax income | -1.19B-62.2% | -733M-157.2% | 1.28B-90.6% | 13.6B-23.4% | 17.8B+10805.8% | |
| Income tax | 96.5M+819.6% | -13.4M-104.8% | 277M-92.5% | 3.70B-34.1% | 5.62B+3163.2% | |
| -1.29B-78.6% | -720M-171.5% | 1.01B-89.9% | 9.92B-18.5% | 12.2B+70146.0% | ||
| Net income to common | -1.29B-78.6% | -720M-171.5% | 1.01B-89.9% | 9.92B-18.5% | 12.2B+70146.0% | |
| -$5.32-77.5% | -$3.00-172.3% | $4.14-89.6% | $39.73-15.2% | $46.87+68420.0% | ||
| EPS (basic) | -$5.32-77.5% | -$3.00-171.6% | $4.19-89.7% | $40.80-18.2% | $49.89+72828.9% | |
| Weighted-avg shares (basic) | 242M+0.5% | 240M-0.1% | 241M-1.1% | 243M-0.3% | 244M+3.7% | |
| Weighted-avg shares (diluted) | 242M+0.5% | 240M-0.9% | 243M-2.8% | 250M-3.8% | 260M+4.5% | |
| Dividends per share | — | — | — | $2.11 | — | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 19.0B-2.9% | 19.5B-9.3% | 21.6B-8.1% | 23.5B+37.4% | 17.1B+732.5% | ||
| Cash & equivalents | 9.02B-11.1% | 10.1B-21.2% | 12.9B-13.3% | 14.8B+674.4% | 1.92B+28.8% | |
| Accounts receivable | 1.09B-28.6% | 1.52B-36.1% | 2.38B-68.9% | 7.65B-45.5% | 14.0B+6788.4% | |
| Inventory | 130M-55.8% | 294M-25.4% | 395M-16.0% | 470M-17.3% | 569M+621.8% | |
| 25.9B+10.4% | 23.4B-7.8% | 25.4B+2.0% | 24.9B+38.9% | 17.9B+528.7% | ||
| Property, plant & equipment | 1.27B+30.7% | 972M+16.3% | 836M+28.2% | 652M+78.5% | 365M+30.8% | |
| Goodwill | 433M+9.3% | 396M-1.2% | 400M+511.1% | 65.5M+0.0% | 65.5M-0.9% | |
| Total non-current assets | 6.87B+77.3% | 3.87B+0.8% | 3.84B+164.5% | 1.45B+69.0% | 859M+7.2% | |
| 2.52B-4.0% | 2.62B+14.7% | 2.29B-27.6% | 3.16B-19.9% | 3.94B+429.0% | ||
| Short-term & current debt | — | — | — | — | 147M+1214.3% | |
| 3.25B+0.3% | 3.24B+6.4% | 3.05B-11.6% | 3.45B-22.6% | 4.46B+282.9% | ||
| Long-term debt | — | — | — | — | 194M-31.6% | |
| 22.6B+12.0% | 20.2B-9.7% | 22.4B+4.2% | 21.5B+59.3% | 13.5B+698.3% | ||
| Total equity incl. non-controlling | 22.6B+12.0% | 20.2B-9.7% | 22.4B+4.2% | 21.5B+59.3% | 13.5B+698.3% | |
| Common shares outstanding | 251M+4.7% | 240M+0.9% | 238M-2.3% | 243M+0.3% | 243M | |
| Shares outstanding (cover) | 251M+4.7% | 240M+0.9% | 238M-1.4% | 241M-2.4% | 247M+2.2% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Cash from operations | 516M+129.7% | 225M-96.1% | 5.81B-59.3% | 14.3B+1257.4% | 1.05B+6936.8% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt issued | 7.58M | 0.00-100.0% | 324K-61.5% | 842K | 0.00-100.0% | |
| Long-term debt repaid | 20.4M+718.7% | 2.49M+2200.6% | 108K-99.5% | 19.8M-68.2% | 62.2M+3310.4% | |
| Common stock issued | 0.00 | 0.00 | 0.00-100.0% | 116M-38.9% | 190M-77.8% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00-100.0% | 509M | 0.00 | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 23.9B-12.5% | 27.3B+7.5% | 25.4B-31.4% | 37.1B-41.7% | 63.6B+223.2% | |
| P/E | — | — | 2.6×-15.9% | 3.0×-41.7% | 5.2×-99.5% | |
| P/S | 7.4×-19.9% | 9.2×+557.9% | 1.4×-15.5% | 1.7×-41.7% | 2.8×-92.1% | |
| P/B | 1.1×-21.9% | 1.4×+14.4% | 1.2×-56.9% | 2.8×-41.7% | 4.7×-59.5% | |
| Earnings yield | — | — | 39.0%+18.8% | 32.8%+71.6% | 19.1%+21637.0% | |
| Dividend yield | — | — | — | 1.4% | — | |
| Source filing | 20-F | 20-F | 20-F | 20-F | 20-F/A |
About this data
Source: BNTX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all BNTX filings on SEC EDGAR → Not investment advice.